Did COVID‐19 Pandemic Change the Course of Multiple Sclerosis? A Retrospective Eight‐Year Study
The COVID-19 pandemic did not affect the course of MS in long-term follow-up. The only factor associated with relapse activity during the pandemic period was disease activity in the pre-pandemic period. COVID-19 vaccination may be an essential tool in the care of MS patients.
Authors
- Anetta Lasek‐Bal (ORCID: https://orcid.org/0000-0003-2481-7528)
- Katarzyna Maciejowska (ORCID: https://orcid.org/0000-0003-2636-5115)
- Marta Konieczna
- Przemysław Puz (ORCID: https://orcid.org/0000-0002-7787-5660)
- Zofia Tarnawska
- Zofia Nowakowska
- Mateusz Glodny
Institutions
- Medical University of Silesia (PL)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/hsr2.71649
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00